Search

everythinglearnresearchcommunity

for

Search:↓

Understanding hair follicles through various models can help develop new treatments for hair disorders.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The study found that steroids and tetracycline helped treat active Lichen planopilaris, and hair transplants were good for later stages.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

People with lichen planus have higher bad cholesterol and lower good cholesterol, increasing their risk for heart disease.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Etanercept may cause lichen planopilaris, so doctors should be cautious.